Core Laboratories (CLB) Other Accumulated Expenses (2022 - 2026)

Core Laboratories' Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $17.4 million for Q1 2026.

• On a quarterly basis, Other Accumulated Expenses rose 78.81% year-over-year to $17.4 million in Q1 2026; TTM through Mar 2026 was $17.4 million, a 78.81% increase from a year earlier, with the FY2025 full-year figure at $16.7 million, up 104.49% from the prior year.
• Other Accumulated Expenses improved to $17.4 million in Q1 2026 per CLB's latest filing, from $16.7 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $17.4 million in Q1 2026 and bottomed at $7.7 million in Q4 2023.
• The 5-year median for Other Accumulated Expenses is $9.1 million (2025), against an average of $10.1 million.
• Across the five-year window, Other Accumulated Expenses fell 8.48% in 2023 and jumped 104.49% in 2025, its largest moves.
• Year by year, Other Accumulated Expenses stood at $8.4 million in 2022, then retreated by 8.48% to $7.7 million in 2023, then climbed by 6.61% to $8.2 million in 2024, then soared by 104.49% to $16.7 million in 2025, then gained by 4.15% to $17.4 million in 2026.
• Per Business Quant, the three latest CLB Other Accumulated Expenses figures stand at $17.4 million (Q1 2026), $16.7 million (Q4 2025), and $9.3 million (Q3 2025).